BACK TO ALL STUDIES

External Quality Assurance (EQA) Program for SARS-CoV-2 Antibody Assay Monitoring (SAAM)

PRIMARY OBJECTIVE(s)

The SARS-CoV-2 Antibody Assay Monitoring (SAAM) program is designed to provide an external quality assurance (EQA) program to laboratories that are performing clinical endpoint assays for Phase 3 clinical trials in support of the US Government plan to develop countermeasures against SARS-CoV-3, formerly named Operation Warp Speed (OWS).

PRINCIPAL INVESTIGATOR(S)

Thomas Denny, MSc,PHil

CONTACT
Thomas Denny, MSc,PHil
thomas.denny@duke.edu
TREATMENT/CLINICAL & LAB INVESTIGATION
POPULATION
FULL NAME OF DIAGNOSTIC TEST
Lab Used for Diagnostic Test
Full Name of Serology/Antibody Test
Lab Used for Serology/Antibody Test
Want more information about this study?
study website